PNC Financial Services Group
PDSB icon

PNC Financial Services Group’s PDS Biotechnology PDSB Stock Holding History

PNC Financial Services Group’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.94K Hold
11,900
– – ﹤0.01% 4225
2026
Q2 		$10.5K Buy
+11,900
New +$12.6K ﹤0.01% 4064
2024
Q2 		– Sell
-8
Closed -$32 – 4881
2024
Q1 		$32 Hold
8
– – ﹤0.01% 4669
2023
Q4 		$40 Buy
+8
New +$40 ﹤0.01% 4580
2022
Q1 		– Sell
-1,000
Closed -$8K – 4659
2021
Q4 		$8K Buy
+1,000
New +$10.8K ﹤0.01% 3854
2020
Q3 		– Sell
-300
Closed -$1K – 4011
2020
Q2 		$1K Hold
300
– – ﹤0.01% 3859
2020
Q1 		$0 Hold
300
– – ﹤0.01% 4019
2019
Q4 		$1K Hold
300
– – ﹤0.01% 3901
2019
Q3 		$1K Hold
300
– – ﹤0.01% 3934
2019
Q2 		$2K Hold
300
– – ﹤0.01% 3877
2019
Q1 		$2K Hold
300
– – ﹤0.01% 3886
2018
Q4 		$2K Hold
300
– – ﹤0.01% 3870
2018
Q3 		$5K Hold
300
– – ﹤0.01% 3824
2018
Q2 		$6K Buy
+300
New +$6.26K ﹤0.01% 3805

Other funds holding PDSB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Militia Capital Management
Militia Capital Management Austin, Texas $4B AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $96.6B AUM 22.52% 1-Year Est. Return
Quantinno Capital Management
Quantinno Capital Management New York $106B AUM 29.93% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
William Blair & Company
William Blair & Company Chicago, Illinois $38.6B AUM 22.09% 1-Year Est. Return

PNC Financial Services Group's PDSB Position: Q3 2026 in Review

PNC Financial Services Group held its PDS Biotechnology (PDSB) position steady in Q3 2026 at 11,900 shares worth $8.94K. The position accounts for ﹤0.01% of the portfolio, ranked #4225.

PNC Financial Services Group first reported a position in PDSB in Q2 2018 and has held it in 14 quarters since. The position peaked at $10.5K in Q2 2026. 48 funds tracked by Wall St. Rank hold PDSB as of Q3 2026.

  • PNC Financial Services Group held 11,900 shares of PDS Biotechnology worth $8.94K as of Q3 2026.
  • PNC Financial Services Group left its PDS Biotechnology share count unchanged in Q3 2026.
  • PDS Biotechnology made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4225 holding.
  • PNC Financial Services Group first reported a position in PDS Biotechnology in Q2 2018 and has held it in 14 quarters since.
  • PNC Financial Services Group's PDS Biotechnology position peaked at $10.5K in Q2 2026.
  • 48 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.